GSK Luxembourg has strengthened its investment funds and regulatory practice with the hiring of Arne Bolch as a partner. Bolch advises clients on fund formation, investment fund mergers and acquisitions and regulatory compliance matters, with a particular focus on Reserved Alternative Investment Funds (RAIFs) and Undertakings for Collective Investment in Transferable Securities vehicles. For further analysis of the evolving Luxembourg funds market, see “Luxembourg Fund Structures Evolve to Meet the Needs of the Private Fund Industry” (Oct. 13, 2016); and our two-part series on the RAIF: “Facilitates Access to AIFMD Passport and Marketing to E.U. Investors for Non-E.U. Hedge Fund Managers” (Apr. 21, 2016); and “Offers Marketing Options and Tax Benefits for Non-E.U. Hedge Fund Managers” (Apr. 28, 2016).